top of page

Kite Pharma's Kristi Shaw talks cell therapy at #JPM23

Kite’s Kristi Shaw discusses BCMA, moving CAR-T into earlier lines of treatment, and focusing on improving auto programs vs diving more into allo.



Comentarios


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page